Skip to content
OpenCapital
Get started

MEI Pharma LITS Q1 2026 earnings

Reported May 13, 2026 · Before market open

Diluted EPS-$0.66Beat by $2.46
Revenue estimate$5.4M
EPS estimate-$3.12

Next report

Sep 18, 2026 (in 2 months)
Revenue estimate$5.4M
EPS estimate-$3.12

Versus estimates

Diluted EPS

Q1 2026-$0.66Beat by $2.46
Q4 2025-$0.82Q3 2025-$0.12Q2 2025-$0.40Q1 2025-$0.39Q4 2024-$0.40Beat by $1.80

Ask the moment MEI Pharma reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did MEI Pharma report Q1 2026 earnings?
MEI Pharma (LITS) reported Q1 2026 earnings on May 13, 2026 before market open.
What were MEI Pharma's Q1 2026 revenue and EPS?
MEI Pharma reported diluted EPS of $-0.66 for Q1 2026.
Did MEI Pharma beat estimates in Q1 2026?
EPS beat the consensus estimate of $-3.12 by $2.46.
How did MEI Pharma's Q1 2026 results compare year-over-year?
Compared to the same quarter a year prior, diluted EPS declined 69.2% from $-0.39.
Where can I find MEI Pharma's Q1 2026 SEC filings?
You can read the 8-K earnings release (0001193125-26-220697) and the 10-Q periodic report (0001193125-26-220687) directly on SEC EDGAR. The filing index links above go to sec.gov.